Working… Menu

A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04069260
Recruitment Status : Terminated (Due to study design limitations, this study has been discontinued and will not proceed with the 2nd cohort as contemplated in the original protocol.)
First Posted : August 28, 2019
Last Update Posted : May 27, 2020
Information provided by (Responsible Party):
Eloxx Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 17, 2019
Actual Study Completion Date : December 17, 2019